| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/25/2000 | CA2349238A1 Systemic viral/ligand gene delivery system and gene therapy |
| 05/25/2000 | CA2348825A1 Maize dna ligase i orthologue and uses thereof |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348479A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
| 05/25/2000 | CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies |
| 05/25/2000 | CA2346965A1 Methods for validating polypeptide targets that correlate to cellular phenotypes |
| 05/25/2000 | CA2340468A1 Methods of facilitating vascular growth |
| 05/25/2000 | CA2317723A1 Root-specific promoter |
| 05/24/2000 | EP1003120A1 Computerized method and apparatus for analyzing nucleic acid assay readings |
| 05/24/2000 | EP1002877A2 Gene amplifying method |
| 05/24/2000 | EP1002870A1 Androgen- and progesteron-receptor binding Hormone Response Element |
| 05/24/2000 | EP1002869A1 A chemically synthesised artificial promotor for high level expression of transgenes and a method for its synthesis |
| 05/24/2000 | EP1002868A1 Method to control gene expression in bacteria namely rhyzobiaceae to improve root nodule development nitrogen fixation and plant biomass production |
| 05/24/2000 | EP1002867A1 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment |
| 05/24/2000 | EP1002866A1 TEMPERATURE SENSITIVE dtsR GENES |
| 05/24/2000 | EP1002865A1 Adipose specific protein |
| 05/24/2000 | EP1002864A1 HIgR and related V domain for the manufacture of a medicament for preventing or treating HSV-1, HSV-2 and BHV infections |
| 05/24/2000 | EP1002863A1 A potassium channel member of the erg family |
| 05/24/2000 | EP1002862A1 Methods of diagnosing or treating neurological diseases |
| 05/24/2000 | EP1002861A1 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 05/24/2000 | EP1002860A1 Method for purification and manipulation of nucleic acids using paramagnetic particles |
| 05/24/2000 | EP1002264A2 Method and apparatus for providing a bioinformatics database |
| 05/24/2000 | EP1002138A1 Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of hiv-1 |
| 05/24/2000 | EP1002137A1 Denaturing multi ion polynucleotide chromatography for detecting mutations |
| 05/24/2000 | EP1002136A2 Use of prothymosin in the diagnosis and treatment of endometriosis |
| 05/24/2000 | EP1002135A1 Method for identifying genes |
| 05/24/2000 | EP1002134A1 Detection of wheat fungal pathogens using the polymerase chain reaction |
| 05/24/2000 | EP1002132A1 90 human secreted proteins |
| 05/24/2000 | EP1002128A1 Characterising nucleic acids |
| 05/24/2000 | EP1002126A1 Improved method for isolating and recovering target dna or rna molecules having a desired nucleotide sequence |
| 05/24/2000 | EP1002125A1 Assaying nucleotides in solution using a fluorescent intensity quenching effect |
| 05/24/2000 | EP1002124A1 Selective ligation and amplification method |
| 05/24/2000 | EP1002120A1 Chimeric adenoviral vectors |
| 05/24/2000 | EP1002119A1 Targeted hsv vectors |
| 05/24/2000 | EP1002118A1 Processes for increasing the yield in plants |
| 05/24/2000 | EP1002117A1 Methods for producing carotenoid compounds, and speciality oils in plant seeds |
| 05/24/2000 | EP1002116A2 Stress tolerance and delayed senescence in plants |
| 05/24/2000 | EP1002115A1 Universal chloroplast integration and expression vectors, transformed plants and products thereof |
| 05/24/2000 | EP1002114A1 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants |
| 05/24/2000 | EP1002113A2 Plant amino acid biosynthetic enzymes |
| 05/24/2000 | EP1002112A1 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide |
| 05/24/2000 | EP1002111A2 Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
| 05/24/2000 | EP1002110A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 05/24/2000 | EP1002109A1 Protein producing cell containing multiple copies of a desired gene and a screenable marker but no selection marker |
| 05/24/2000 | EP1002108A2 Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/24/2000 | EP1002107A1 Mass production method of antimicrobial peptide and dna construct and expression system thereof |
| 05/24/2000 | EP1002106A1 Production and use of recombinant protein multimers with altered biological activity |
| 05/24/2000 | EP1002105A1 Fusion proteins comprising coiled-coil structures derived of bovine if1 atpase inhibitor protein |
| 05/24/2000 | EP1002104A1 Novel metalloprotease |
| 05/24/2000 | EP1002103A1 A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof |
| 05/24/2000 | EP1002102A1 Cellulose degrading enzymes of aspergillus |
| 05/24/2000 | EP1002101A2 Antifreeze proteins, dna and expression systems |
| 05/24/2000 | EP1002100A2 Method for producing and identifying new hydrolases having improved properties |
| 05/24/2000 | EP1002099A1 Synaptojanin isoform |
| 05/24/2000 | EP1002098A1 Mutant alpha-amylase having introduced therein a disulfide bond |
| 05/24/2000 | EP1002097A2 Dehydrogenases with improved nad-dependence, the production thereof, and their use |
| 05/24/2000 | EP1002096A1 Cytokinin oxidase |
| 05/24/2000 | EP1002095A1 Improved protein expression strains |
| 05/24/2000 | EP1002094A1 Method for the production of para-hydroxybenzoate in pseudomonas mendocina |
| 05/24/2000 | EP1002093A1 Preparation and use of recombinant influenza a virus m2 constructs and vaccines |
| 05/24/2000 | EP1002092A1 Mimotopes of hypervariable region 1 of the e2 glycoprotein of hcv and uses thereof |
| 05/24/2000 | EP1002091A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 05/24/2000 | EP1002090A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES |
| 05/24/2000 | EP1002089A1 Plant genes encoding dr1 and drap1, a global repressor complex of transcription |
| 05/24/2000 | EP1002088A1 A plant homolog of yeast ada2, a transcription adaptor |
| 05/24/2000 | EP1002087A1 Method of increasing fruit size in a plant |
| 05/24/2000 | EP1002086A1 Materials and methods relating to a plant regulatory protein |
| 05/24/2000 | EP1002085A1 Methods and means for control of flowering in plants |
| 05/24/2000 | EP1002084A1 Mammalian cytokine: interleukin-b30 and related reagents |
| 05/24/2000 | EP1002083A1 Aprotinin variants with improved properties and bikunins of aprotinin variants |
| 05/24/2000 | EP1002082A2 Transcriptional silencer protein nrf |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002080A1 Fluorescent proteins as cell-type specific reporter |
| 05/24/2000 | EP1002079A2 Novel inhibitor of cellular proliferation |
| 05/24/2000 | EP1002078A1 Method enabling readministration of aav vector via immunosuppresion of host |
| 05/24/2000 | EP1002077A1 Secreted proteins encoded by human chromosome 13 |
| 05/24/2000 | EP1002076A1 Proteins mediating switch recombination |
| 05/24/2000 | EP1002075A1 Adipocyte-specific protein homologs |
| 05/24/2000 | EP1002074A1 Calcium-binding phosphoprotein |
| 05/24/2000 | EP1002073A2 Cell activation process and reagents therefor |
| 05/24/2000 | EP1002072A1 Human semaphorin e and polynucleotides encoding it |
| 05/24/2000 | EP1002071A1 Human glial cell line-derived neurotrophic factor promoters, vectors containing same, and methods of screening compounds therewith |
| 05/24/2000 | EP1002070A1 Human atp-binding cassette transport protein |
| 05/24/2000 | EP1002069A1 Peptides containing the motif igd and their use as cell migration modulators |
| 05/24/2000 | EP1002068A1 Mutations in the myostatin gene cause double-muscling in mammals |
| 05/24/2000 | EP1002067A1 Strong early seed-specific gene regulatory region |
| 05/24/2000 | EP1002063A1 Cloning and characterization of a human adenylyl cyclase |
| 05/24/2000 | EP1002062A1 STARCH CONVERSION PROCESS USING THERMOSTABLE ISOAMYLASES FROM $i(SULFOLOBUS) |
| 05/24/2000 | EP1002060A1 Alkaline xyloglucanase |
| 05/24/2000 | EP1002058A1 Isolation and identification of novel polymerases |
| 05/24/2000 | EP1002056A1 NOVEL ppGpp SYNTHETASE AND EXPRESSION SYSTEMS FOR IMPROVED PRODUCTION OF PROTEIN OF INTEREST |
| 05/24/2000 | EP1002051A2 PROBIOTIC STRAINS FROM $i(LACTOBACILLUS SALIVARIUS) AND ANTIMICROBIAL AGENTS OBTAINED THEREFROM |
| 05/24/2000 | EP1001991A1 CRYSTAL STRUCTURES OF ANTI-FACTOR IX Fab FRAGMENTS AND METHODS OF USE FOR PEPTIDOMIMETIC DESIGN |
| 05/24/2000 | EP1001990A1 Protein that binds trail |
| 05/24/2000 | EP1001989A1 Prolactin secretion modulator |
| 05/24/2000 | EP1001987A2 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 05/24/2000 | EP1001985A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 05/24/2000 | EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS |
| 05/24/2000 | EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS |
| 05/24/2000 | EP1001982A1 Cardiotrophin-like cytokine |